Akari Therapeutics (AKTX) Share-based Compensation Growth (1y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 206.26% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -69.95% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 0.18% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.66% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 23.70% |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -69.95% |
| Dec 31, 2025 | -290.45% |
| Sep 30, 2025 | 176.21% |
| Jun 30, 2025 | 61.57% |
| Mar 31, 2025 | 242.91% |
| Dec 31, 2024 | 278.41% |
| Sep 30, 2024 | -18.69% |
| Jun 30, 2024 | 61.23% |
| Mar 31, 2024 | 11.70% |
| Jun 30, 2023 | 124.65% |
| Mar 31, 2023 | 168.12% |
| Jun 30, 2022 | 49.64% |
| Mar 31, 2022 | 16.43% |
| Dec 31, 2021 | 3.00% |
| Sep 30, 2021 | -3.00% |
| Jun 30, 2021 | 100.00% |
| Mar 31, 2021 | -100.00% |
| Dec 31, 2020 | -231,204,897.46% |
| Sep 30, 2020 | 178,287,803.46% |
| Jun 30, 2020 | -24,535,851.54% |
| Mar 31, 2020 | 25,480,139.02% |
| Dec 31, 2019 | -74.61% |
| Sep 30, 2019 | -65.97% |
| Jun 30, 2019 | 16.38% |
| Mar 31, 2019 | -17.13% |
| Dec 31, 2018 | -17.51% |
| Sep 30, 2018 | -16.12% |
| Jun 30, 2018 | -57.31% |
| Mar 31, 2018 | -48.44% |
| Dec 31, 2017 | -60.71% |
| Sep 30, 2017 | -52.96% |
| Jun 30, 2017 | 2.38% |
| Mar 31, 2017 | 13.02% |
| Dec 31, 2016 | 502.30% |
| Sep 30, 2016 | 23.87% |